fbpx

Quality Use of Medicines (QUM) Alliance

PSA is proud to be an integral member of the Quality Use of Medicines (QUM) Alliance, addressing safety and quality use of medicines issues across the management of eczema, gout, the use of antidepressants, and oral anticoagulants in at-risk populations.

 

Click on the links below to discover quality use of medicines education and resources.

Link to Eczema webpage
Link to Antidepressants in older adults
Link image to Gout

QHUB is the centralised location for quality use of medicines education and resources. Pharmacists will find multidisciplinary education offerings, factsheets and other resources here.

QHUB logo

What is the QUM Alliance?

Taking a consortium approach for collective impact on national health topics

The Quality Use of Medicines Alliance is a unique consortium of health sector organisations representing quality use of medicines expertise, education providers, researchers, colleges, peak bodies, member-based organisations, and consumer groups.

 

The QUM Alliance was formed in 2023 to address national health priorities with national programs of health professional education and consumer health literacy. With funding from the Australian Government Department of Health and Aged Care, the first areas addressed include eczema, gout, antidepressants in older adults and anticoagulants for atrial fibrillation.

 

Further funding has been secured for the next three years to address 5 new topics including  antidepressants in teens and young adults, menopause, secondary stroke prevention, osteoporosis following a fracture and complex multimorbidity in older adults.

 

The Quality Use of Medicines Alliance includes:

 

The Quality Use of Medicines Alliance will collaborate with a wide range of health and consumer organisations for a further three years until January 2028.

QUM Alliance logos